Take home messages The number of patients transplanted using Haplo-HSCT is increasing consistently in Europe and United States. Haplo-HSCT with the use of PTCy for GVHD prophylaxis, allows low incidence of grade III to IV acute GVHD, chronic GVHD, and comparable survival with HLA-matched unrelated and cord blood transplantation.
Unmanipulated haploidentical transplantation for adult patients with hematological malignancies
Santoro, Nicole
2019-01-01
Abstract
Take home messages The number of patients transplanted using Haplo-HSCT is increasing consistently in Europe and United States. Haplo-HSCT with the use of PTCy for GVHD prophylaxis, allows low incidence of grade III to IV acute GVHD, chronic GVHD, and comparable survival with HLA-matched unrelated and cord blood transplantation.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
HemaSphere - 2019 - Ruggeri - Unmanipulated haploidentical transplantation for adult patients with hematological.pdf
accesso aperto
Tipologia:
PDF editoriale
Dimensione
240.54 kB
Formato
Adobe PDF
|
240.54 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
